MedPath

Software for COVID19 Detection from Chest X-Ray, CT or Ultrasonography

Not Applicable
Registration Number
CTRI/2020/07/026351
Lead Sponsor
PurplAS IT Services Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

This study poses no additional health risk associated with standard Chest X-Ray, CT or Ultrasound procedures.

The medical information that will be collected from you if you take part in this study includes:

Your chest X-Ray, CT or Ultrasound Scan/Video.

You may be asked to take an RT-PCR or any other COVID19 confirmatory test.

Your Health data may be recorded for presence of any pre-existing diseases

Exclusion Criteria

Patients with conditions preventing them from undergoing standard chest X-Ray, CT or Ultrasound procedures.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The entire project aims to develop a market ready Artificial Intelligence based object recognition software capable of working on Real-time live Chest Radio-Imaging data like CT Scans, Ultrasound, and X-Ray as well as integrate the same with hardware prototype(s) capable of running the software.Timepoint: 2 Sub-phases: <br/ ><br>Data Collection & Testing: 4 weeks (Sensitivity Benchmarks will be outcome) <br/ ><br>Testing & Validation: 6 weeks (replication of Outcome/Sensitivity Benchmarks of week 4 over clinical scenario) <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Collection of Chest Radio-Imaging data like CT Scans, Ultrasound, and X-Ray from multiple COVID-19 patients and Refining of AI models for COVID19 detectionTimepoint: 4 weeks from start of trials;Test and validate sensitivity and reliability of COIVD19 identification in Controlled clinical scenarioTimepoint: 6 weeks from end of Secondary Outcome 1
© Copyright 2025. All Rights Reserved by MedPath